Federation des caisses Desjardins du Quebec’s Sarepta Therapeutics SRPT Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-50	Closed	-$855	–	2980
2025 Q2	$855	Hold	50	–	–	﹤0.01%	2523
2025 Q1	$3.19K	Hold	50	–	–	﹤0.01%	2256
2024 Q4	$6.08K	Hold	50	–	–	﹤0.01%	2029
2024 Q3	$6.25K	Buy	+50	New	+$6.91K	﹤0.01%	2025
2021 Q2	–	Sell	-648	Closed	-$48.3K	–	2569
2021 Q1	$48.3K	Buy	648 +496	+326%	+$45.8K	﹤0.01%	1556
2020 Q4	$25.9K	Buy	+152	New	+$22.5K	﹤0.01%	1678
2020 Q1	–	Sell	-189	Closed	-$24.4K	–	2357
2019 Q4	$24.4K	Buy	189 +100	+112%	+$10.1K	﹤0.01%	1683
2019 Q3	$6.7K	Hold	89	–	–	﹤0.01%	1900
2019 Q2	$13.5K	Hold	89	–	–	﹤0.01%	1777
2019 Q1	$10.6K	Buy	+89	New	+$11.4K	﹤0.01%	1656
2018 Q1	–	Sell	-100	Closed	-$5.56K	–	2215
2017 Q4	$5.56K	Hold	100	–	–	﹤0.01%	1851
2017 Q3	$4.54K	Hold	100	–	–	﹤0.01%	1841
2017 Q2	$3.37K	Hold	100	–	–	﹤0.01%	1950
2017 Q1	$2.96K	Buy	+100	New	+$3.1K	﹤0.01%	1617

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's SRPT Position: Q3 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 50 shares — an estimated $855 sold.

Federation des caisses Desjardins du Quebec first reported a position in SRPT in Q1 2017 and held it in 14 quarters. The position peaked at $48.3K in Q1 2021. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

Federation des caisses Desjardins du Quebec reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 50 Sarepta Therapeutics shares in Q3 2025, an estimated $855.
Federation des caisses Desjardins du Quebec first reported a position in Sarepta Therapeutics in Q1 2017 and held it in 14 quarters.
Federation des caisses Desjardins du Quebec's Sarepta Therapeutics position peaked at $48.3K in Q1 2021.
319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2025, filed 14 Nov 2025.